Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor-Reference-Cited by-同舟云学术

Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor

Published:2009-04 Issue:4 Volume:18 Page:501-508
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Gimsing Peter¹

Affiliation:

1. Associate Professor Faculty of Health Sciences University of Copenhagen, University Hospital Rigshospitalet, Department of Hematology, 2100 Copenhagen, Denmark ; ;

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543780902852560

Reference38 articles.

1. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

2. Novel Sulfonamide Derivatives as Inhibitors of Histone Deacetylase

3. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

4. Deacetylase Enzymes

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in the research of epigenetic regulators in cancer therapy;SCIENTIA SINICA Vitae;2023-11-01

2. Identification and characterization of new degradation products of belinostat using UHPLC-Q-TOF-MS/MS and in silico toxicity prediction;Journal of Liquid Chromatography & Related Technologies;2021-04-03

3. The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells;Molecules;2021-04-02

4. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures;BMC Bioinformatics;2020-06-05

5. Epigenetic therapies in acute myeloid leukemia: the role of hypomethylating agents, histone deacetylase inhibitors and the combination of hypomethylating agents with histone deacetylase inhibitors;Chinese Medical Journal;2020-02-07